On Wednesday, Halozyme Therapeutics, Inc. (HALO) stock saw a decline, ending the day at $53.46 which represents a decrease of $-0.36 or -0.67% from the prior close of $53.82. The stock opened at ...

Former Certain Affinity developer Mike Clopper revealed the canceled Halo Infinite battle royale mode, codenamed Project ...

GAMMA Investing LLC increased its stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 67.7% during ...

Certain Affinity designer confirms that Halo Infinite's unannounced battle royale mode has been cancelled, says it would've ...

The canceled Halo battle royale mode was real and could have been a game changer for the franchise, says a former developer.